Skip to main content

Blog

PepGen Announces First Patient Dosed in CONNECT1-EDO51 Phase 2 Clinical Trial of PGN-EDO51

...

Race to End Duchenne Celebrates Runners During Walt Disney World Marathon Weekend

...

The Importance of Assisted Cough

...

Thank You for Fighting for Every Future With Us

...

Dyne Therapeutics Announces Positive Initial Clinical Data from DELIVER Trial in Duchenne Patients

...

Give by midnight to double your impact in the fight for every future

...

Give Before Midnight Tomorrow. Fight for Every Future!

...

Your Gift to Support PPMD’s Gene Therapy Initiative Goes Twice as Far Now Through 12/31

...

Sarepta Therapeutics Submits Efficacy Supplement to Expand the ELEVIDYS Label

...

PPMD & Community Partners Urge Timely, Transparent FDA Review of EMBARK Data

...